SCHEMBL7003675

SCHEMBL7003675

Cc1cc([C@@H]2C[C@H]2C(=O)O)ccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.51
SLC6A2 P23975 6/20 0.47
SLC6A3 Q01959 6/20 0.47
SLC6A4 P31645 5/20 0.47
CHRNA1 P02708 3/20 0.47
CHRNG P07510 3/20 0.47
ITGA5 P08648 3/20 0.47
CHRNB1 P11230 3/20 0.47
CHRNB2 P17787 3/20 0.47
CHRNB4 P30926 3/20 0.47
CHRNA3 P32297 3/20 0.47
CHRNA4 P43681 3/20 0.47
CHRND Q07001 3/20 0.47
IDO1 P14902 3/20 0.44
KMO O15229 2/20 0.43
CCR2 P41597 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8152908 1.00 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4CHRNA1
SCHEMBL7003669 1.00 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4CHRNA1
SCHEMBL27426841 1.00 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4CHRNA1
SCHEMBL8152906 1.00 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4CHRNA1
SCHEMBL8149382 0.87 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4IDO1
SCHEMBL8149379 0.87 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4IDO1
SCHEMBL7002249 0.87 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4IDO1
SCHEMBL7002253 0.87 FFAR1 (0.51) FFAR1SLC6A2SLC6A3SLC6A4IDO1
SCHEMBL6998514 0.85 KMO (0.54) FFAR1SLC6A2SLC6A3SLC6A4IDO1
SCHEMBL14301510 0.85 FFAR1 (0.55) FFAR1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed